The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement of Appointments

11 Mar 2009 09:49

RNS Number : 6731O
Phorm Inc
11 March 2009
 



Phorm, Inc. ("Phorm" or the "Company")

Announcement of Appointments 

 

Phorm (AIM: PHRM and PHRX), the online advertising technology company, is pleased to announce the appointments of Sarah Simon as Financial and Strategic Development Officer and Mike Moore as Global Commercial Director. 

Sarah will have responsibility for the management of investor, analyst and shareholder relationships and financial communications. She will also provide analysis, research and strategic guidance to the business on all financial issues. Sarah reports to Phorm's CEO, Kent Ertugrul.

Sarah joins from Morgan Stanley where she spent 15 years and was a Managing Director in European Equity Research. She started her career in corporate finance, working on mergers and acquisitions, IPOs and restructuring then moved to equity research where she spent 12 years specialising in coverage of the European Media and Internet market. 

Mike will join Phorm on April and will be responsible for managing the fast-growing commercial opportunities for Phorm's technology as it is deployed globally. This will include overseeing partnership arrangements with advertisers and publishers to ensure the optimal performance of ad campaigns served through the Open Internet Exchange (OIX) Mike will report to Phorm's deputy CEO, Nan Richards.

Mike joins from the Telegraph Media Group (TMG) where he held the role of General Manager - Digital with overall P&L responsibility for Digital Operations and Marketing. While with TMG, Mike authored and executed its digital monetisation and publishing strategy, the implementation of which helped significantly boost the global audience of Telegraph.co.uk from 9 to 22 million unique users, making it one of the most visited UK newspaper sites worldwide. 

Prior to TMG, Mike held high level sales, interactive marketing and commercial development roles at AOL Europe and America Online.

Kent Ertugrul, CEO of Phorm, commented: "Sarah and Mike have in depth experience of the Internet industry that is highly relevant to Phorm. Sarah has a distinguished track record of analysis and communication on media and internet stocks within the financial sector. Meanwhile Mike has the necessary relevant expertise in delivering successful digital media strategies. Their appointments will significantly strengthen our capabilities, both in terms of driving our business strategy and fully developing the commercial opportunities that flow from our innovative technology."

End

For Phorm Enquiries:

David Sawday - Communications Director 

Maria Greenwood - Press Officer 

Tel: 0207 297 2537

About Phorm: 

Phorm is an innovative advertising technology company specialising in precision targeted advertising which preserves users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

Phorm is a Delaware, US incorporated company, with offices in New York and London. 

The Company was admitted to the AIM market of the London Stock Exchange in 2004 

and has over 100 employees.

 

For more information, please visit: www.phorm.com http://www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADGGMFLMNGLZG
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.